Citations (25)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
R. Rupp, D. Hurley, S. Grayson, J. Li, K. Nolan, R.D. McFetridge, J. Hartzel, C. Abeygunawardana, M. Winters, H. Pujar, P. Benner & L. Musey. (2019) A dose ranging study of 2 different formulations of 15-valent pneumococcal conjugate vaccine (PCV15) in healthy infants. Human Vaccines & Immunotherapeutics 15:3, pages 549-559.
Read now
Read now
Marta Moreira, Olga Castro, Melissa Palmieri, Sofia Efklidou, Stefano Castagna & Bernard Hoet. (2017) A reflection on invasive pneumococcal disease and pneumococcal conjugate vaccination coverage in children in Southern Europe (2009–2016). Human Vaccines & Immunotherapeutics 13:6, pages 1242-1253.
Read now
Read now
Sara Boccalini, Ornella Varone, Martina Chellini, Luca Pieri, Antonino Sala, Cesare Berardi, Paolo Bonanni & Angela Bechini. (2017) Hospitalizations for pneumonia, invasive diseases and otitis in Tuscany (Italy), 2002-2014: Which was the impact of universal pneumococcal pediatric vaccination?. Human Vaccines & Immunotherapeutics 13:2, pages 428-434.
Read now
Read now
Silvio Tafuri, Francesca Fortunato, Maria Giovanna Cappelli, Vanessa Cozza, Angela Bechini, Paolo Bonanni, Domenico Martinelli & Rosa Prato. (2015) Effectiveness of vaccination against varicella in children under 5 years in Puglia, Italy 2006–2012. Human Vaccines & Immunotherapeutics 11:1, pages 214-219.
Read now
Read now
Angela Bechini, Cristina Taddei, Alessandro Barchielli, Miriam Levi, Emilia Tiscione, Maria Grazia Santini, Fabrizio Niccolini, Maria Teresa Mechi, Donatella Panatto, Daniela Amicizia, Chiara Azzari, Paolo Bonanni & Sara Boccalini. (2015) A retrospective analysis of hospital discharge records for S. pneumoniae diseases in the elderly population of Florence, Italy, 2010–2012. Human Vaccines & Immunotherapeutics 11:1, pages 156-165.
Read now
Read now
Articles from other publishers (20)
Matteo Astengo, Chiara Paganino, Daniela Amicizia, Laura Sticchi, Andrea Orsi, Giancarlo Icardi, Maria Francesca Piazza, Salini Mohanty, Francesca Senese, Gian Marco Prandi & Filippo Ansaldi. (2022) Incidence of Hospitalisation and Emergency Department Visits for Pneumococcal Disease in Children, Adolescents, and Adults in Liguria, Italy: A Retrospective Analysis from 2012–2018. Vaccines 10:9, pages 1375.
Crossref
Crossref
Elisa Barbieri, Gloria Porcu, Tianyan Hu, Tanaz Petigara, Francesca Senese, Gian Marco Prandi, Antonio Scamarcia, Luigi Cantarutti, Anna Cantarutti & Carlo Giaquinto. (2022) A Retrospective Analysis to Estimate the Burden of Invasive Pneumococcal Disease and Non-Invasive Pneumonia in Children <15 Years of Age in the Veneto Region, Italy. Children 9:5, pages 657.
Crossref
Crossref
Enrique Chacon-Cruz & Erika Z Lopatynsky. (2021) Continuous Effectiveness of Pneumococcal 13-Valent Conjugate Vaccine on Pediatric Pneumococcal Otomastoiditis: Results of 15 Years of Active/Prospective Surveillance in a Mexican Hospital on the Mexico-US Border. Cureus.
Crossref
Crossref
Melike Yildirim, Pinar Keskinocak, Stephen Pelton, Larry Pickering & Inci Yildirim. (2020) Who is at risk of 13-valent conjugated pneumococcal vaccine failure?. Vaccine 38:7, pages 1671-1677.
Crossref
Crossref
Hanna Rinta-Kokko, Kari Auranen, Maija Toropainen, J. Pekka Nuorti, Hanna Nohynek, Lotta Siira & Arto A. Palmu. (2020) Effectiveness of 10-valent pneumococcal conjugate vaccine estimated with three parallel study designs among vaccine-eligible children in Finland. Vaccine 38:6, pages 1559-1564.
Crossref
Crossref
J.C.De Moraes, X.M. Pérez Porcuna, J. Nieto-Guevara, A. Eisman, B. Torres, J.L. Gonzalez Redondo & X. Saez-Llorens. (2020) Vaccination with conjugate vaccines against pneumococcal disease: What really matters. Vacunas (English Edition) 21:1, pages 23-40.
Crossref
Crossref
J.C. De Moraes, X.M. Pérez Porcuna, J. Nieto-Guevara, A. Eisman, B. Torres, J.L. Gonzalez Redondo & X. Saez-Llorens. (2020) Vacunación frente a la enfermedad neumocócica con vacunas conjugadas: ¿qué es lo que verdaderamente importa?. Vacunas 21:1, pages 23-40.
Crossref
Crossref
Marcelo C. Scotta, Paulo J.C. Marostica & Renato T. Stein. 2019. Kendig's Disorders of the Respiratory Tract in Children. Kendig's Disorders of the Respiratory Tract in Children
427
438.e4
.
Elena Chiappini, Federica Inturrisi, Elisa Orlandini, Maurizio de Martino & Chiara de Waure. (2018) Hospitalization rates and outcome of invasive bacterial vaccine-preventable diseases in Tuscany: a historical cohort study of the 2000–2016 period. BMC Infectious Diseases 18:1.
Crossref
Crossref
Marta Inês Cazentini Medeiros, Samanta Cristine Grassi Almeida, Maria Luiza Leopoldo Silva Guerra, Paulo da Silva, Ana Maria Machado Carneiro & Denise de Andrade. (2017) Distribution of Streptococcus pneumoniae serotypes in the northeast macro-region of São Paulo state/Brazil after the introduction of conjugate vaccine. BMC Infectious Diseases 17:1.
Crossref
Crossref
Godwin Oligbu, Yingfen Hsia, Laura Folgori, Sarah Collins & Shamez Ladhani. (2016) Pneumococcal conjugate vaccine failure in children: A systematic review of the literature. Vaccine 34:50, pages 6126-6132.
Crossref
Crossref
Adamos Hadjipanayis, Elisavet Efstathiou, Maria Alexandrou, Loukia Panayiotou, Chrystalla Zachariadou, Panayiotis Petrou & Vasiliki Papaevangelou. (2016) Nasopharyngeal Pneumococcal Carriage among Healthy Children in Cyprus Post Widespread Simultaneous Implementation of PCV10 and PCV13 Vaccines. PLOS ONE 11:10, pages e0163269.
Crossref
Crossref
Wei-Ju Su, Hsiu-Yun Lo, Chia-Hsuin Chang, Luan-Yin Chang, Cheng-Hsun Chiu, Ping-Ing Lee, Chun-Yi Lu, Yu-Chia Hsieh, Mei-Shu Lai & Tzou-Yien Lin. (2016) Effectiveness of Pneumococcal Conjugate Vaccines of Different Valences Against Invasive Pneumococcal Disease Among Children in Taiwan. Pediatric Infectious Disease Journal 35:4, pages e124-e133.
Crossref
Crossref
Kirsten F Ward, Marianne Trent, Brynley P Hull, Helen E Quinn, Aditi Dey & Robert I Menzies. (2015) Evaluating the implementation of the 13-valent pneumococcal vaccine supplementary dose program in Australian primary health care settings. BMC Health Services Research 15:1.
Crossref
Crossref
Makoto Shiragami, Akiko Mizukami, Oscar Leeuwenkamp, Tomas Mrkvan, Emmanuelle Delgleize, Yuichi Kurono & Satoshi Iwata. (2015) Reply to Farkouh RA et al. Comment on “Cost-Effectiveness Evaluation of the 10-Valent Pneumococcal Non-Typeable Haemophilus Influenzae Protein D Conjugate Vaccine and 13-Valent Pneumococcal Vaccine in Japanese Children”. Infectious Diseases and Therapy 4:2, pages 235-244.
Crossref
Crossref
Jukka Jokinen, Hanna Rinta-Kokko, Lotta Siira, Arto A. Palmu, Mikko J. Virtanen, Hanna Nohynek, Anni Virolainen-Julkunen, Maija Toropainen & J. Pekka Nuorti. (2015) Impact of Ten-Valent Pneumococcal Conjugate Vaccination on Invasive Pneumococcal Disease in Finnish Children – A Population-Based Study. PLOS ONE 10:3, pages e0120290.
Crossref
Crossref
Francesca Fortunato, Domenico Martinelli, Maria Giovanna Cappelli, Vanessa Cozza & Rosa Prato. (2015) Impact of Pneumococcal Conjugate Universal Routine Vaccination on Pneumococcal Disease in Italian Children. Journal of Immunology Research 2015, pages 1-6.
Crossref
Crossref
Vincenzo Baldo, Silvia Cocchio, Roberta Lazzari, Patrizia Furlan, Chiara Bertoncello, Francesca Russo, Mario Saia & Tatjana Baldovin. (2015) Estimated hospitalization rate for diseases attributable to Streptococcus pneumoniae in the Veneto region of north-east Italy. Preventive Medicine Reports 2, pages 27-31.
Crossref
Crossref
Fatim Ba, Abdoulaye Seck, Mamadou Bâ, Aliou Thiongane, Moussa Fafa Cissé, Khady Seck, Madeleine Ndour, Pascal Boisier & Benoit Garin. (2014) Identifying an appropriate PCV for use in Senegal, recent insights concerning Streptococcus pneumoniaeNP carriage and IPD in Dakar. BMC Infectious Diseases 14:1.
Crossref
Crossref
Vincenzo Baldo, Silvia Cocchio, Tatjana Baldovin, Alessandra Buja, Patrizia Furlan, Chiara Bertoncello, Francesca Russo & Mario Saia. (2014) A population-based study on the impact of hospitalization for pneumonia in different age groups. BMC Infectious Diseases 14:1.
Crossref
Crossref